Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04170296 · ClinicalTrials.gov registry record · Phase 3
Real World CCH Study in Adult Females With Cellulite
A Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 153
- Enrollment target
NCT04170296: Completed Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT04170296 is a Phase 3 study that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04170296, a Phase 3 study, has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 153 participants
- Enrollment target
Study Summary
This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or moderate EFP in the buttocks.
Interventions
- DRUG EN3835
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2021-01-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04170296
The ClinicalTrials.gov registry entry for NCT04170296 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EN3835 is the first listed.
NCT04170296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04170296 about?
NCT04170296 is a clinical study titled "Real World CCH Study in Adult Females With Cellulite". This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thi...
What is the current status of trial NCT04170296?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 153 participants. The study started on 2019-11-01. Estimated completion is 2021-01-08.
What interventions are being tested in trial NCT04170296?
The interventions under investigation include: EN3835 (DRUG).
Who is sponsoring clinical trial NCT04170296?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.